LEADER 02223nam  2200637   450 
001 9910820454903321
005 20231110224848.0
010   $a1-119-10916-7
010   $a1-119-10915-9
035   $a(CKB)3710000000635588
035   $a(EBL)4462536
035   $a(PQKBManifestationID)16202679
035   $a(PQKBWorkID)14832014
035   $a(PQKB)24979578
035   $a(MiAaPQ)EBC4462536
035   $a(DLC)  2015044827
035   $a(Au-PeEL)EBL4462536
035   $a(CaPaEBR)ebr11189928
035   $a(CaONFJC)MIL909472
035   $a(OCoLC)946262128
035   $a(MiAaPQ)EBC7104434
035   $a(Au-PeEL)EBL7104434
035   $a(JP-MeL)3000111387
035   $a(EXLCZ)993710000000635588
100   $a20160413d2017      uy|            0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 14$aThe dental foundation interview guide $ewith situational judgement tests /$fZahid Siddique, Shivana Anand, Helena Lewis-Greene
210  1$aChichester, West Sussex :$cWiley Blackwell,$d2017.
215   $a1 online resource (187 p.)
225 1 $aNew York Academy of Sciences 
300   $aIncludes index.
311   $a1-119-10914-0 
320   $aIncludes bibliographical references and index.
327   $aWhat is dental foundation training? -- The application process -- The SJT exam -- Definitions and legalities -- Important notes for revision -- Practice scenarios -- Situational judgement test practice questions -- How to write a dental C.V.
410  0$aNew York Academy of Sciences 
606   $aDental offices$xPersonnel management
606   $aDentistry$xExaminations$vStudy guides
606   $aDentists$vExaminations, questions, etc
615  0$aDental offices$xPersonnel management.
615  0$aDentistry$xExaminations
615  0$aDentists
676   $a617.60071/141
700   $aSiddique$b Zahid$f1985-$01596237
702   $aAnand$b Shivana$f1990-
702   $aLewis-Greene$b Helena$f1954-
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910820454903321
996   $aThe dental foundation interview guide$93917539
997   $aUNINA

LEADER 01560nam  2200361z- 450 
001 9910689868203321
005 20050503161022.0
035   $a(CKB)5860000000031857
035   $a(BIP)012315030
035   $a(EXLCZ)995860000000031857
100   $a20220406c2004uuuu  -u-         -
101 0 $aeng
200 10$aPublication and disclosure issues in antidepressant pediatric clinical trials $ehearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, second session, September 9, 2004
215   $a1 online resource (iii, 716 p.) $cill
311   $a0-16-074184-X 
517   $aPublication and Disclosure Issues in Antidepressant Pediatric Clinical Trials
606   $aAntidepressants$zUnited States$xEvaluation
606   $aDepression in children$xChemotherapy$zUnited States$xEvaluation
606   $aClinical trials$zUnited States
610   $aAntidepressants
610   $aDepression in children
610   $aClinical trials
610   $aMedical care
610   $aMedical
610   $aPsychology
615  0$aAntidepressants$xEvaluation.
615  0$aDepression in children$xChemotherapy$xEvaluation.
615  0$aClinical trials
712 02$aUnited States, Congress House Committee on Energy and Commerce Subcommittee on Oversight and Investigations Staff,$4oth
906   $aBOOK
912   $a9910689868203321
996   $aPublication and disclosure issues in antidepressant pediatric clinical trials$93171204
997   $aUNINA